Daniel Tillett

Follow
Get notifications in MyBN when activity occurs.
Subscribe to BN Log In
Daniel Tillett
Daniel Tillett
Chief Executive Officer, Managing Director / Race Oncology

Dr Daniel Tillett is the founder and chief executive of Nucleics, a private Australian biotechnology company producing and selling DNA sequencing software to the genomics industry.

Dr Tillett has over 20 years of commercial experience in the biotech industry in project management, sales and marketing, IP management, fund raising and startup investing.

He was previously a senior lecturer within the School of Pharmacy at La Trobe University where he taught and researched in the areas of pharmacy, phage therapy, microbiology, bioinformatics and cancer.

Dr Tillett has more than 40 scientific publications and granted patents in molecular biology, microbiology, genetics and biochemistry.

Lists and Charts

Roles

2019
Chief Executive Officer, Managing Director
Race Oncology
Year started and most recent title

Total Shareholder Return as at 02/10/25

Rank Company 1 Yr 5 Yr
327th K2 Asset Management Holdings 76.44% 14.18%
328th Atlas Pearls 75.74% 102.88%
329th Race Oncology 75.35% 31.87%
330th Lord Resources 75.27% 0%
331st West African Resources 75.21% 23.22%
View Full List
1701 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Share Transactions

28/03/23
$50.00k Issued
Simble Solutions
28/03/23
Issued
Simble Solutions
07/02/23
$13.04k Bought
Race Oncology
Total value as at the date of the transaction
Powered by Morningstar ®

    Related Information

    Access to our data for Daniel Tillett is only available to paid subscribers with Data & Insights access.

    Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.

    Daniel Tillett is linked to 1 organisation which is included in 1 list - Public Companies - non WA.

    To see the data you will need to Subscribe.

    X